Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia-Reference-Cited by-同舟云学术

Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia

Published:2008-08 Issue:1-3 Volume:590 Page:327-332
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Kostapanos Michael S.,Milionis Haralampos J.,Lagos Konstantinos G.,Rizos Christos B.,Tselepis Alexandros D.,Elisaf Moses S.

Publisher

Elsevier BV

Subject

Pharmacology

Reference33 articles.

1. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels;Ai;Am. J. Cardiol.,2008

2. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin;Baldassarre;Int. J. Cardiol.,2005

3. Once daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin;Bays;Prev. Cardiol.,2003

4. Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia;Caslake;Atherosclerosis,2003

5. Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia;Empen;Nutr. Metab. Cardiovasc. Dis.,2003

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of statin therapy on glycemic control and insulin resistance: A systematic review and meta-analysis;European Journal of Pharmacology;2023-05

2. Rosuvastatin and co-enzyme Q10 improve high-fat and high-fructose diet-induced metabolic syndrome in rats via ameliorating inflammatory and oxidative burden;Biomedicine & Pharmacotherapy;2022-09

3. Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2020-12-31

4. Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2019-03-19

5. Pathophysiology of Diabetic Dyslipidaemia;Current Vascular Pharmacology;2017-09-28